LA JOLLA PHARMACEUTICAL COMPANY RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2013 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
This Restricted Stock Agreement (the “Agreement”) is made as of April 29, 2013 (the “Effective Date”) by and between La Jolla Pharmaceutical Company, a California corporation (the “Company”), and James Rolke (“Recipient”).
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2013 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
This Restricted Stock Agreement (the “Agreement”) is made as of April 10, 2012 (the “Effective Date”) by and between La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”), and James Rolke (“Recipient”).
LA JOLLA PHARMACEUTICAL COMPANY RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2013 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
This Restricted Stock Agreement (the “Agreement”) is made as of September 24, 2013, by and between La Jolla Pharmaceutical Company, a California corporation (the “Company”), and Stacey Ruiz (“Recipient”).
LA JOLLA PHARMACEUTICAL COMPANY RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2013 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
This Restricted Stock Agreement (the “Agreement”) is made as of September 24, 2013, by and between La Jolla Pharmaceutical Company, a California corporation (the “Company”), and George Tidmarsh (“Recipient”).
LA JOLLA PHARMACEUTICAL COMPANY RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • December 20th, 2013 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
This Restricted Stock Agreement (the “Agreement”) is made as of September 24, 2013, by and between La Jolla Pharmaceutical Company, a California corporation (the “Company”), and Saiid Zarrabian (“Recipient”).
